Drugs / BU
last change Apr 2010 re-read 2 minutes ago

BU

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00350181 Background Aug 2006 → Aug 2007 acute graft versus host disease, leukemia, non-Hodgkin lymphoma Stanford University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BU ClinicalTrials.gov intervention name — accepted as the source's own label NCT00350181
Route Intravenous “BU 1 mg/kg every 6hr x 4 doses, IV” NCT00350181